Advertisement
Screener

DarioHealth Corp. (DRIO) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

1.9 / 5 stars · 38/98 Roast Me

DarioHealth Corp. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • DarioHealth Corp. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-12-31 was 0.00 shares, a 100.00% decline year-over-year.
  • DarioHealth Corp. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 4.00K shares.
  • DarioHealth Corp. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-12-31 was 2.02K shares.
  • DarioHealth Corp. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-09-30 was 0.00 shares.
  • DarioHealth Corp. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 8.69K shares, a 27.44% increase from fiscal 2023.
  • DarioHealth Corp. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 6.82K shares.
  • DarioHealth Corp. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 40.55K shares.
  • DarioHealth Corp. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 0.00 shares, a 100.00% decline from fiscal 2019.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month
2024-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10
8.69K shares
10-K · filed 2025-03-10
2024-09-304.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
2023-12-312.02K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
6.82K shares
10-K · filed 2024-03-28
2023-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
2021-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
40.55K shares
10-K · filed 2023-03-09
2021-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
40.55K shares
derived: sum of 4 quarters · filed 2021-11-15
2021-06-306.77K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
40.55K shares
derived: sum of 4 quarters · filed 2021-08-16
2021-03-3133.77K shares
10-Q · filed 2021-05-17
2020-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09
0.00 shares
10-K · filed 2021-03-09
2020-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
2019-12-31-7.70K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17
406.00 shares
10-K · filed 2020-03-17
2019-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28
2019-06-308.10K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
2019-03-310.00 shares
10-Q · filed 2019-05-13
2018-12-310.00 shares
10-K · filed 2019-03-25
2017-12-3191.86K shares
10-K · filed 2018-03-19
2016-12-310.00 shares
10-K · filed 2017-03-22
2015-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-08
6.00K shares
10-K · filed 2016-02-08
2015-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13
2015-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12
2015-03-316.00K shares
10-Q · filed 2015-05-14
2014-12-3174.50K shares
10-K · filed 2015-03-24
2013-12-3115.00K shares
10-K · filed 2014-03-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
CVRx, Inc. (CVRX)United States$0.067B-2.62
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
TELA Bio, Inc. (TELA)United States$0.057B-0.82
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Spectral AI, Inc. (MDAI)United States$0.052B
Pulmonx Corp (LUNG)United States$0.082B-1.16
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
LENSAR, Inc. (LNSR)United States$0.087B2.02